European Field Elm (Ulmus minor Mill.): A Comprehensive Reference
1. Identity and Botanical Description
1.1 Nomenclature and Taxonomy
The field elm, known botanically as Ulmus minor Mill. (synonym: Ulmus campestris Auct. non L.), is probably the most polymorphic of all European elms. The synonym Ulmus campestris appears widely in older pharmacopeial and supplement literature, and the two names are used interchangeably in both traditional and modern commercial contexts, though contemporary botanical authorities recognize Ulmus minor as the accepted name. Additional synonyms encountered in the literature include Ulmus foliacea, Ulmus carpinifolia, and Ulmus nitens. The plant belongs to the family Ulmaceae and the genus Ulmus, which is naturally distributed throughout the northern hemisphere in Eurasia, North America, and Northern Africa.
1.2 Morphological Description
The Ulmus campestris is an especially large, deciduous tree found throughout the greater part of Europe, North Africa, Asia Minor, and Japan. The tree grows 60 to 100 feet high, often attaining a height of 120 feet and 40 to 50 feet in girth, sending out numerous spreading branches extending 30 to 40 feet from its trunk. Under optimal conditions, the tree can grow up to 45 m and live 400–500 years. Its oval-shaped, alternate leaves are rough-textured and double-toothed, forming a green, billowy mass upon its limbs; small reddish-green flowers appear before spring foliage and give way to winged seeds maturing in April–May. The tree's corky, gray bark is scored by grand vertical furrows.
1.3 Common Names
In German the tree is known as Feld-Ulme or Rüster; in French as Orme champêtre or Ormeau; in Italian as Olmo campestre; and in English as Common Elm or Field Elm. In supplement contexts, particularly gemmotherapy, the plant is most commonly labeled as "European Field Elm."
1.4 Parts Used and Common Preparations
Traditionally, the bark and leaves of the European Field Elm were utilized in folk remedies to address a variety of ailments. The inner bark is the primary medicinal part. The dried inner bark of Ulmus campestris presents as a tough brownish-yellow bark, about half a line thick, without smell, with a mucilaginous, slightly bitter, and astringent taste.
Modern commercial preparations span several categories:
- Bark decoctions and infusions: A classic preparation described in older pharmacopeial literature is Decoctum Ulmi, prepared 1 in 8, with a dose of 2 to 4 fl. oz.
- Gemmotherapy bud extracts: Gemmotherapy preparations use European Field Elm bud extract in a natural glycerin and organic ethanol medium, filtered and potentized at a 1/10th dilution (1X Hahnemannian) in a pure water, natural glycerin, and organic ethanol medium. Each drop (medicinal ingredient) provides Ulmus campestris 1DH (1:200) 0.05 ml, equivalent to 0.25 mg of elm buds.
- Powdered bark: Used both internally and topically.
- Topical poultices: Poultices made from the bark were applied to minor cuts, burns, and ulcers.
2. Traditional and Historical Use
2.1 Ancient Greco-Roman Medicine
Historically, Ulmus minor was utilized as an astringent and cicatrizing agent since ancient times, with Dioscorides noting its efficacy in healing wounds and purifying the body. The German-language pharmacopeial compendium by Madaus, documented at Henriette's Herbal, corroborates that the elm belongs to the medicinal plants already known in antiquity, and Dioscorides recognized the astringent action of the leaves, branches, and bark, using them for bone fractures, skin diseases, as a wound remedy, and as a mucus-loosening agent.
2.2 Medieval and Early Modern European Herbalism
Traditional varieties documented by herbalists include U. procera (English Elm), U. campestris (Wild Elm), U. laevis (White Elm), and U. montanus (Mountain Elm). Avicenna noted that "the Bark and Root have similar properties," classifying elm as cold (though Salmon noted warm) and dry; he recorded that a decoction of the bark in water and wine cleanses phlegm, and full doses purge phlegm. Sixteenth-century herbalists including Matthiolus (1563 and 1586) and Lonitzer (1578) documented extensive topical and internal uses. Uses recorded include a hip bath for excess menstruation, washes to cleanse the skin and face, decoctions applied topically for fractures (Lonicerus), and leaf juice applied with vinegar to dandruff, chronic eczema, psoriasis, and leprosy; Avicenna stated "the leaves, barks and buds are suitable for treating abscesses," and Salmon noted that the liquor in the blisters of the leaves removes pimples, spots, freckles, and heals fresh wounds.
Traditional dosage of the bark in decoction was recorded as 6–18 grams, with up to 28 grams used in some cases.
2.3 Pharmacopeial Recognition in Europe
According to King's American Dispensatory (1898), Ulmus campestris, Linné, or European elm, was official in the French Codex, being used, like slippery elm, for the production of a mucilage, and, being astringent, was employed against tapeworms and in chronic skin affections, syphilitic or otherwise. Traditional medicinal actions attributed to the Common Elm include tonic, demulcent, astringent, and diuretic properties; it was formerly employed for the preparation of an antiscorbutic decoction recommended in cutaneous diseases of a leprous character, such as ringworm.
2.4 Folk Use in Digestive and Respiratory Conditions
Herbalists prized the inner bark for its demulcent qualities; when prepared as a tea or poultice, it was commonly used to soothe inflamed mucous membranes, treat sore throats, and alleviate coughs. The mucilaginous nature of the bark was particularly valued for calming digestive discomforts such as gastritis and ulcers. It was described as an excellent demulcent employed as an emollient application, and internally was especially recommended in suppression of urine, inflammation of the bladder, dysentery, and diarrhea.
2.5 Gemmotherapy Tradition (20th Century Onwards)
Gemmotherapy, also known as phytoembryotherapy, is a modern method of biotherapeutic drainage using the extracts of various trees and shrubs. Gemmotherapy, or bud therapy, belongs to the family of herbal therapies that use plants to help prevent and treat various health problems; gemmotherapy uses only the embryonic tissues of fresh plants, trees, and shrubs — that is to say, buds, young shoots, and roots. Gemmotherapy is very popular in European countries such as France, Belgium, Italy, and Germany, as well as in some areas of Eastern Europe. Within this tradition, European Field Elm (Ulmus campestris) became a prominent remedy primarily associated with skin and metabolic conditions.
3. Key Constituents and Active Compounds
3.1 Bark Constituents (Mature Plant)
Elm bark contains approximately 3 percent tannic acid, 20 percent mucilage, and a peculiar brown body called ulmin, which is insoluble in water. A vegetable principle called Ulmin or Ulmic Acid was first discovered in the gummy substance that spontaneously exudes in summer from the bark of the Common Elm; it becomes by the action of air a dark-brown, almost black substance, without smell or taste, insoluble in cold water but sparingly soluble in boiling water, soluble in alcohol, and readily dissolved by alkaline solutions.
Identified constituents of Ulmus campestris include ascorbic acid, beta-sitosterol, beta-carotene, caprylic acid, decanoic acid (capric acid), flavonoids, salicylic acid, tannin, ulmic acid, ulmicin, and ulmin, as well as sesquiterpenes.
Mucilage is abundant in the barks of both Ulmus rubra and U. campestris; raffinose and stachyose also occur in Ulmus.
3.2 Secondary Metabolites Across the Ulmus Genus
Secondary metabolites in the aerial parts of Ulmus plants are generally categorized into catechin glycosides (CG) and flavonoid glycosides (FG). Previous phytochemical investigations on the genus Ulmus have identified diverse types of compounds, including flavonoids, terpenoids, lignans, coumarins, and glycosides. Research on closely related species (including U. davidiana, U. parvifolia, U. macrocarpa, and U. pumila) has documented the following secondary metabolites that are characteristic of the genus:
- Several secondary metabolites such as catechin, catechin-7-O-α-L-rhamnopyranoside, catechin-3-O-α-L-rhamnopyranoside, lyoniside, (−)-lyoniresinol, (+)-lyoniresinol nudiposide, triterpenes, flavanones, and phenolics have been reported in the root bark of U. davidiana var. japonica.
- Additionally, (−)-catechin-7-O-β-D-apiofuranoside, (−)-catechin, procyanidin B3, phloridzin, fraxetin, isovanillic acid, and vanillic acid have been isolated from the root bark of U. parvifolia; sterol, sterol-glucoside, catechin-7-O-α-L-rhamnopyranoside, rutin, and isoquercetin have been isolated from its stem bark and leaves.
- Flavonoids and coumarins have been isolated from the root bark of U. macrocarpa.
- Activity-guided isolation from the roots of U. macrocarpa yielded three flavonoids — catechin 7-O-β-D-apiofuranoside, (+)-catechin, and taxifolin 6-C-glucopyranoside — and one coumarin, fraxin.
3.3 Constituents of Gemmotherapy (Bud) Preparations
Meristematic tissues used for gemmotherapy extracts contain many phytonutrients; these gemmotherapy extracts (GTEs) usually contain, besides secondary metabolites, proteins, amino acids, hormones, vitamins, growth factors, and cytokines. The best time to harvest the buds is late winter or early spring, as this is when the maximum concentration of active ingredients is present. For Ulmus campestris bud preparations specifically, listed constituents include ascorbic acid, auxins (IAA), beta-sitosterol, beta-carotene, brassinosteroids (BR), caprylic acid, decanoic acid, cytokinins (CK), flavonoids, gibberellins (GA), jasmonic acid (JA), meristematic plant stem cells, salicylates (SA), and three sesquiterpenes including 7-hydroxycalamenal and 7-hydroxycalamenene.
3.4 Silica
From a therapeutic standpoint, the properties of Ulmus minor are described as strongly "marked" by its affinity for silicon; the species exhibits significant therapeutic properties, particularly due to its high silica content. Within gemmotherapy frameworks, the presence of silica in Ulmus minor is held to stimulate regeneration and purification of connective tissues, influencing its therapeutic effectiveness.
4. Proposed Mechanisms of Action
4.1 Demulcent and Mucilaginous Action
The mucilage of elm is described as a splendid demulcent for irritable and irritated or inflamed mucous membranes, relieving dryness of the tissues of the mouth and throat and alleviating cough. The high mucilage content (approximately 20% in the bark) is mechanistically responsible for the plant's soothing and coating actions on irritated mucosal surfaces. This mechanism is shared across the Ulmus genus.
4.2 Anti-Inflammatory Mechanisms via Flavonoids and Catechins
To investigate the antioxidative and anti-inflammatory effects of compounds isolated from elm species, DPPH radical scavenging activity and inhibitory activity against nitric oxide (NO) production in LPS-stimulated RAW 264.7 cells were examined, along with the expression of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) by RT-PCR and Western Blotting in HaCaT cells. Compounds isolated from U. macrocarpa showed moderate antioxidative activities; NO production was reduced and the expressions of iNOS and COX-2 and their mRNA were inhibited by these compounds. These mechanisms are relevant to the Ulmus genus more broadly. Flavonoids can interfere with enzyme activity involved in the metabolism of arachidonic acid, suppressing the formation of inflammatory mediators, and are effective inhibitors of pro-inflammatory enzymes such as lipoxygenase (LOX) and cyclooxygenase (COX).
4.3 Astringent Action via Tannins
The approximately 3% tannic acid content in elm bark is responsible for its astringent properties, which are understood to precipitate surface proteins, reduce tissue permeability, and form a protective layer over irritated or damaged mucous membranes and skin. This mechanism underpins traditional uses in wound healing, diarrhea management, and skin conditions. Pharmacopeial literature notes that incompatibles for elm bark preparations include persalts of iron, salts of lead and silver, and gelatin — all consistent with tannin-rich preparations.
4.4 Antioxidant Properties
Studies on Ulmus pumila bark investigated the influence of extraction conditions on antioxidant activities and catechin content; extracts were evaluated for DPPH and ABTS radical scavenging activities, reducing power, and total phenolic and proanthocyanidin contents. The 99% EtOH for 3-hour extracts exhibited the highest antioxidant abilities with the highest phenolic and proanthocyanidin contents. Although this work concerns a related species (U. pumila), it reflects genus-wide polyphenolic antioxidant capacity.
4.5 Effects on Bone Metabolism
The focus of a 2024 systematic review in Fitoterapia was on catechin glycosides and flavonoid glycosides as key compounds identified for their potential benefits in the Ulmus genus; the research highlights the extracts' role in enhancing bone mineral density (BMD) by stimulating osteoblast activity and suppressing osteoclast differentiation, suggesting a protective effect against osteoporosis.
5. Scientific Evidence by Area of Use
5.1 Skin and Dermatological Conditions
Ulmus minor is recognized for its astringent, soothing, and purifying properties, considered effective against eczema and wounds. Ancient texts note its use for healing scabies and broken bones based on its mucilage-rich inner bark. In gemmotherapy practice, in terms of the integumentary system, Ulmus campestris has a greater affinity for weeping lesions such as eczemas, acnes, herpes, and psoriatic lesions.
Evidence status: No controlled human clinical trials have been identified that specifically examine Ulmus minor for dermatological outcomes. The evidence base is composed entirely of traditional use accounts and gemmotherapy practitioner reports. At the national and international level, gemmotherapy is practiced with products not standardized in active principles responsible for the therapeutic action. The potential for healing is claimed based on traditional medicine and clinical evidence, although no relationship has been established between the effect, on one side, and their composition and properties, on the other side.
5.2 Gastrointestinal Health
The mucilaginous nature of the bark was traditionally considered particularly effective in calming digestive discomforts such as gastritis and ulcers, offering gentle relief to those suffering from gastrointestinal distress. Historical pharmacopeial use included preparation of mucilaginous remedies for inflammatory conditions of the digestive and urinary tract.
Evidence status: Evidence is restricted to historical and traditional reports. From a scientific perspective, research into the specific health benefits of European Field Elm remains in its early stages. No human clinical trials have been retrieved assessing the effect of Ulmus minor bark preparations on gastrointestinal outcomes. Some in-vitro and animal-model research on related species (e.g., U. davidiana var. japonica) provides indirect biological plausibility for anti-inflammatory effects on gut tissue, but this cannot be directly extrapolated to U. minor preparations.
5.3 Anti-Inflammatory and Antioxidant Activity
A 2024 systematic review in Fitoterapia investigated the therapeutic effects of Ulmus species extracts, traditionally used as tea ingredients in East Asia, on bone health and inflammatory conditions. Through the analysis of 9,757 studies, narrowing down to 56 pertinent ones, the safety and efficacy of Ulmus extracts were evaluated. The extracts demonstrated significant anti-inflammatory properties by modulating inflammatory markers and pathways. The findings confirm the historical use of Ulmus extracts in East Asia for health benefits and recommend further exploration into functional foods and nutraceuticals.
Evidence status: These findings apply to the Ulmus genus broadly and are predominantly based on in-vitro and animal studies. The review specifically concerns East Asian species and their catechin and flavonoid glycosides. Direct clinical evidence for Ulmus minor per se remains absent.
5.4 Bone Health and Osteoporosis
Catechin glycosides and flavonoid glycosides identified in Ulmus genus extracts have been highlighted for their potential benefits; research highlights the role of extracts in enhancing bone mineral density (BMD) by stimulating osteoblast activity and suppressing osteoclast differentiation, suggesting a protective effect against osteoporosis. Work on the Himalayan elm Ulmus wallichiana has yielded a novel flavonoid C-glucoside, GTDF, studied for its ability to preserve bone mineral density, microarchitecture, and biomechanical properties. These results provide new insights into the osteoblast-protective mechanisms of this compound through inducing proliferation and differentiation and reducing the inflammatory responses, indicating it may be developed as an agent for the prevention and treatment of osteoporosis.
Evidence status: Exclusively preclinical (in-vitro and animal models). None of this work has been conducted on Ulmus minor specifically, and no human clinical trials exist for any elm species regarding bone mineral density.
5.5 Respiratory Health
Herbalists prized the inner bark for its demulcent qualities; when prepared as a tea or poultice, it was commonly used to soothe inflamed mucous membranes, treat sore throats, and alleviate coughs. The demulcent and mucilaginous action of elm mucilage is mechanistically plausible for symptom relief in mild respiratory irritation.
Evidence status: Traditional use only. No clinical trials on Ulmus minor for respiratory outcomes have been identified.
5.6 Antimicrobial Activity
Most research on antimicrobial activity focuses on extracts made from differentiated tissues, but in recent years more studies have examined meristematic tissues. This type of tissue contains many phytonutrients used for the preparation of gemmotherapy extracts (GTEs) that may be more complex and potentially more effective than adult plant parts. In reviewing studies on the antimicrobial efficacy of such GTEs, there is only a small amount of research focusing on their efficacy, and this area is largely unexplored.
Evidence status: Preliminary and largely unexplored. No clinical trials targeting antimicrobial properties of Ulmus minor specifically have been identified.
5.7 Wound Healing
The presence of silica in Ulmus minor is proposed to stimulate regeneration and purification of connective tissues; studies referenced in gemmotherapy literature indicate a correlation between silica levels and enhanced wound healing, particularly in chronic dermatological conditions. Mechanistically, mucilage, tannins, and flavonoids each contribute to wound healing through barrier protection, tissue repair stimulation, and reduction of oxidative stress.
Evidence status: Traditional and mechanistic. No controlled clinical trials on Ulmus minor specifically for wound healing have been identified.
6. Body Systems and Health Areas Associated with European Field Elm
- Integumentary system: Recognized for astringent, soothing, and purifying properties, effective against eczema and wounds.
- Gastrointestinal system: Described as an excellent demulcent recommended in inflammation of the bladder, dysentery, and diarrhea.
- Respiratory system: Used to soothe inflamed mucous membranes, treat sore throats, and alleviate coughs.
- Musculoskeletal system: Research on the Ulmus genus highlights a role in enhancing bone mineral density by stimulating osteoblast activity and suppressing osteoclast differentiation.
- Urinary system: Historical demulcent use for inflammatory urinary tract conditions, including suppression of urine and bladder inflammation.
- Metabolic/excretory (gemmotherapy framework): Within gemmotherapy, U. campestris buds are described as supporting kidney and liver drainage, particularly in metabolic skin conditions.
7. Dosage Forms and Reported Dosages
The following dosages are drawn directly from pharmacopeial and product literature; they reflect historical practice or manufacturer labeling and should not be interpreted as clinically validated recommendations.
7.1 Decoction (Bark)
The classical pharmacopeial preparation Decoctum Ulmi is prepared at 1 in 8, with a reported dose of 2 to 4 fl. oz. Traditional bark decoction dosage was 6–18 grams, with up to 28 grams used in some cases.
7.2 Gemmotherapy Liquid Extracts (Bud)
Recommended dose for adults and children over 12 years: 50 drops (1.25 ml) three times daily in a small amount of water, or as recommended by a healthcare practitioner. Each drop (0.025 ml) contains European Field Elm (Ulmus campestris) bud extract (1:200).
One manufacturer's suggested daily use is 10–20 drops directly in the mouth or in a small amount of water, up to three times daily; for acute phase use: 5–10 drops every 2 hours, up to six times daily. For children under 80 lbs., one-half of the recommended adult serving; for infants, one-third.
Gemmotherapy dosage ranges from 5 drops to 50–75 and even 100 drops per day, with recommendations based on the patient's age, condition, and the specific gemmo preparation. Lower doses may be needed for those with digestive or skin conditions or very sensitive individuals, with gradual titration upward advised.
7.3 Standardization Note
At the national and international level, gemmotherapy products are not standardized in active principles responsible for the therapeutic action. This means that reported dosages across preparations are not comparable to standardized extract doses used in clinical research.
8. Safety Considerations and Interactions
8.1 General Safety Profile
As a homeopathic/gemmotherapy product, Ulmus campestris preparations in the United States have not been evaluated by the Food and Drug Administration for safety or efficacy, and the FDA is not aware of scientific evidence to support homeopathy as effective. Pre-clinical safety data on gemmotherapy preparations more broadly show that histologic studies and clinical tests indicated no negative effects of the studied gemmo-derivatives and no significant changes in motor behavior, body weight, and appearance of treated mice. No independent toxicological studies specifically examining Ulmus minor or Ulmus campestris preparations have been retrieved from the peer-reviewed literature.
8.2 Pharmacopeial Incompatibilities (Tannin-Mediated)
Pharmacopeial literature identifies incompatibles for elm bark preparations as persalts of iron, salts of lead and silver, and gelatin — interactions arising from the tannin content, which can precipitate proteins and certain metal salts.
8.3 Mechanical Risks (Bark Preparations)
As the bark increases in bulk by imbibing moisture, its use in the form of bougies for the dilatation of strictures and fistulas has proved troublesome in urethral strictures, from the liability of the part behind the stricture breaking off in the attempt to withdraw it and passing into the bladder. This risk is specific to physical mechanical use of the bark and is not relevant to oral preparations.
8.4 Contraindications Reported for Gemmotherapy Preparations
Contraindications cited for gemmotherapy preparations include: allergies to the plant from which the gemmo is made; allergies to alcohol or glycerin (carrier solvents used in most preparations); pregnancy and breastfeeding; diabetes (listed as a conditional contraindication due to glycerin content); and certain other health conditions.
8.5 Limitations of the Evidence Base
While there is promising evidence from in-vitro and animal studies supporting traditional claims, more rigorous human clinical research is needed to fully validate health benefits and mechanisms of action. The body of research on anti-inflammatory and antioxidant effects applies primarily to the Ulmus genus as a whole, dominated by work on East Asian species including U. davidiana, U. macrocarpa, U. pumila, and U. parvifolia. Direct pharmacological studies on Ulmus minor (European Field Elm) bark or bud preparations are sparse in the peer-reviewed literature; claims made for gemmotherapy preparations of this species rest predominantly on traditional use, gemmotherapy practitioner frameworks, and indirect extrapolation from related species.
References
Go back